Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $56,539 - $70,905
78 Added 17.85%
515 $466,000
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $258,791 - $346,226
437 New
437 $339,000
Q2 2023

Jul 17, 2023

BUY
$350.74 - $468.98 $1.45 Million - $1.94 Million
4,141 New
4,141 $1.94 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pettinga Financial Advisors, LLC Portfolio

Follow Pettinga Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettinga Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pettinga Financial Advisors, LLC with notifications on news.